Evidence Level
Betaine HCl is a commonly utilized supplement in integrative medicine for addressing suspected hypochlorhydria, despite limited rigorous clinical trial evidence. The underlying physiological rationale is well-established: stomach acid plays a critical role in digestion, nutrient absorption, and protection against pathogens, with its production diminishing as individuals age. A study by Yago et al. (2013) demonstrated that Betaine HCl effectively re-acidifies the stomach, significantly lowering gastric pH by 4.5 units in healthy volunteers with rabeprazole-induced hypochlorhydria. However, a notable evidence gap persists due to the absence of large randomized controlled trials (RCTs) evaluating clinical outcomes in patients with functional gastrointestinal disorders.
Martinsen et al. (2005) highlighted the importance of stomach acid as a barrier against infectious diseases, underscoring its role in maintaining gut health and immune defense. While Betaine HCl appears to be a reasonable intervention for suspected hypochlorhydria following exclusion of Helicobacter pylori infection and ulcers, further research is needed to establish its efficacy in diverse clinical populations.
Additionally, Ostojic et al. (2013) explored the co-administration of methyl donors with guanidinoacetic acid (GAA), finding that this combination significantly reduced hyperhomocysteinaemia compared to GAA alone. Although not directly related to Betaine HCl's role in hypochlorhydria, this study underscores the importance of considering nutrient interactions when evaluating supplementation strategies.